BSX News 11.45 10/17/2014 04:32:41 Boston Scientific Corp (B

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Boston Scientific Corp (BSX) 11.45 $BSX

Boston Scientific Announces Pacemaker CE Mark With Options For Magnetic Resonance Imaging
PR Newswire - Thu Oct 16, 3:30PM CDT
Boston Scientific Corporation (NYSE: BSX) has received CE Mark approval for the ACCOLADETM pacemaker family. When implanted with the company's INGEVITYTM leads, ACCOLADE pacemakers are the first to enable patients to receive full-body MRI scans in both 1.5 Tesla and 3.0 Tesla systems. In addition, the Boston Scientific ImageReadyTM technology offers the most flexible MRI options, allowing higher energy scan sequences, and featuring a programmable MRI timer designed to improve patient workflow.12345
BSX: 11.45 (+0.01)

Next Support Level for Boston Scientific (BSX) is $11.29
Comtex SmarTrend(R) - Wed Oct 15, 9:28AM CDT
Shares of Boston Scientific (NYSE:BSX) have bearishly opened below the pivot of $11.68 today and have reached the first support level of $11.43. Investors may be interested in a cross of the next downside pivot targets of $11.29 and $10.90.
BSX: 11.45 (+0.01)

China Interventional Cardiovascular Device Industry Report 2014-2017
M2 - Wed Oct 15, 8:04AM CDT
Research and Markets (http://www.researchandmarkets.com/research/vk2z4c/china) has announced the addition of the "China Interventional Cardiovascular Device Industry Report,2014-2017" report to their offering. The prevalence of cardiovascular disease in China impacted by accelerated aging of population and changes in consumption concept, dietary habit, way of working and other lifestyles has been growing year after year, thereby promoting the development of domestic percutaneous coronary intervention (PCI) market. PCI cases in China totaled 454,505 in 2013, up 16.9% from a year earlier; meanwhile the interventional cardiovascular device industry there was worth RMB20.12 billion. At present, half of the Chinese interventional cardiovascular device industry is dominated by domestic companies led by MicroPort, Lepu Medical, Lifetech Scientific, and Dalian Yinyi. In 2013, 53.4% of the Chinese market was controlled by domestic companies, 31.2% by foreign counterparts represented by Johnson & Johnson, Medtronic, Boston Scientific, Abbott, B. Braun and Terumo, and 15.4% by those invested by Hong Kong, Macao and Taiwan. Affected by the implementation of Regulations on the Centralized Procurement of High-value Medical Consumables, purchase price of interventional cardiovascular devices will continue to decline, further squeezing profit margins of relevant companies. However, the substantial decline in prices will enable more patients to receive PCI, thus helping the industry maintain a fairly rapid growth rate. It is expected that the Chinese interventional cardiovascular device market will worth RMB41.2 billion by 2017. China Interventional Cardiovascular Device Industry Report, 2014-2017 focuses on the following: - Status quo of China interventional cardiovascular device industry, including overview, market demand, import & export, competitive landscape and entry barriers; - Development environment of China interventional cardiovascular device industry, embracing macro environment, policy climate and upstream & downstream sectors; - Status quo, competitive landscape, etc. of China interventional cardiovascular device market segments, covering coronary stent, balloon catheter, catheter, guidewire, sheath group and auxiliary devices; - Operation, interventional cardiovascular device business, etc. of 6 foreign and 12 Chinese interventional cardiovascular device companies. Key Topics Covered: 1. Overview of Interventional Cardiovascular Device Industry 2. Status Quo of China Interventional Cardiovascular Device Industry 3. Development Environment of China Interventional Cardiovascular Device Industry 4. Market Segments of China Interventional Cardiovascular Device Industry 5. Foreign Companies in China 6. Major Domestic Companies 7 Forecast and Outlook Companies Mentioned - Abbott Laboratories - AmsinoMed Medical Device - B. Braun - Boston Scientific - Dalian Yinyi - Demax Medical - JW Medical - Johnson & Johnson - Lepu Medical - Lifetech Scientific - Medtronic - MicroPort - Neich Medical (Shenzhen) - SCW Medicath - Sino Medical - Starway Medical - Synexmed - Terumo For more information visit http://www.researchandmarkets.com/research/vk2z4c/china
BSX: 11.45 (+0.01), JNJ: 96.78 (-1.43), ABT: 39.99 (-0.02), MDT: 61.81 (-0.44)

U.S. Market for Soft Tissue Reinforcement and Regeneration 2015
M2 - Wed Oct 15, 5:22AM CDT
Research and Markets (http://www.researchandmarkets.com/research/69mg7x/u_s_market_for) has announced the addition of the "U.S. Market for Soft Tissue Reinforcement and Regeneration 2015" report to their offering. The U.S. market for soft tissue reinforcement and regeneration includes medical graft devices that are designed to reinforce and regenerate soft tissues. Soft tissues are defined as aggregations of similarly specialized cells which collectively function to connect, support or surround other structures and organs of the body. These tissues include tendons, ligaments, fascia, skin, fibrous tissues, fat, synovial membranes, muscles, nerves and blood vessels. Collagen, the most abundant protein in mammals, is one of the characteristic elements inside the extracellular matrix of soft tissue and, as such, plays a critical role in soft tissue repair. Since soft tissue essentially makes up the majority of a person and there are countless medical conditions associated with soft tissue problems, a select group of large markets related to soft tissue repair will be covered in this report, including breast reconstruction, hernia repair, dural repair, vaginal slings, skin repair, sports medicine and tendon reinforcement, and dental soft tissue regeneration. There are three primary classes of soft tissue repair devices; - Allografts - Xenografts - Alloplasts Key Topics Covered: 1. Executive Summary 2. Research Methodology 3. U.S. Soft Tissue Reinforcement And Regeneration Market 4. Procedures 5. Breast Reconstruction Market 6. Hernia Repair Market 7. Dural Repair Market 8. Vaginal Sling Market 9. Skin Repair Market 10. Sports Medicine And Tendon Reinforcement Market 11. Dental Soft Tissue Regeneration Market 12. Abbreviations Companies Mentioned - Aesculap/B. Braun - American Medical Systems - Arthrex - Atrium Medical - BioHorizons - Boston Scientific - C. R. Bard - Citagenix - Coloplast - Cook Medical - Covidien - Dentsply - Depuy Synthes - Ethicon - Geistlich - Gore Medical - Integra LifeSciences - LifeCell - Medline - Medtronic - MiMedx - Organogenesis - Osiris - RTI Biologics - Smith & Nephew - Stryker - Synovis/Baxter - Systagenix - Wright Medical - Zimmer For more information visit http://www.researchandmarkets.com/research/69...market_for
BSX: 11.45 (+0.01), SNN: 29.39 (-0.42), RTIX: 3.89 (+0.20), MDT: 61.81 (-0.44)

The Canadian Pain Coalition States Urgency to Improve Chronic Pain Awareness and Access to Multidisciplinary Treatment Options
CNW Group - Tue Oct 14, 10:17AM CDT
The Painful Truth Survey Reveals 72% of Chronic Pain Sufferers who have sought treatment are still in pain for 12 hours or more each day, even after many have tried several treatments
BSX: 11.45 (+0.01)

Affordable Housing Project, Lawsuit Settlement, Drug Review, and Earnings Release Schedules - Research Reports on UnitedHealth, Bristol-Myers, Boston Scientific, Abbott and Illumina
PR Newswire - Tue Oct 14, 7:55AM CDT
Today, Analysts Review released its research reports regarding UnitedHealth Group Inc. (NYSE: UNH), Bristol-Myers Squibb Company (NYSE: BMY), Boston Scientific Corporation (NYSE: BSX), Abbott Laboratories (NYSE: ABT) and Illumina Inc. (NASDAQ: ILMN). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7151-100free.
BSX: 11.45 (+0.01), ABT: 39.99 (-0.02), UNH: 85.39 (+3.23), ILMN: 160.23 (+6.64), BMY: 49.22 (+0.26)

Global Ablation Technologies Market Outlook 2014 - 2020
M2 - Tue Oct 14, 4:14AM CDT
Research and Markets (http://www.researchandmarkets.com/research/z8pb7c/ablation) has announced the addition of the "Ablation Technologies Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020" report to their offering. The global market for ablation technologies market has been studied on the basis of application type and technologies type. The application segment has been sub-segmented into these prominent categories namely cardiovascular, gynecology, pain management, oncology, urology, ophthalmology and others. Whereas, the ablation technologies market has been fragmented into radiofrequency, light/laser, electrical, ultrasound, microwave, cryotherapy and others. RF ablation is the most established device type, but ultrasound ablation and cryoablation are growing rapidly owing to advantages associated such as minimal damage to associated tissues among others. Cryoablation devices are the only kind of ablation device that can be used to treat prostate cancer. Urologists and interventional radiologists both use cryoablation to treat kidney cancer using differing techniques. As per an analysis by Center for Disease Prevention and Control (CDC) approximately 5.1 million people face heart failure every year of which one in nine deaths in 2009 were primarily due to cardiac arrhythmia. As per WHO projection, approximately 32 million people are living with some form cancer causing 8 million deaths across the world which clearly depicts scope of opportunities for players operating in the ablation technologies market. Some of the key companies operating in this market include St. Jude Medical, Inc., Bioscience Webster Inc., Medtronic, Inc., Boston Scientific Corp, Covidien PLC and Angiodynamics, Inc. among others. The global ablation technologies market is segmented as follows: Ablation Technologies Market, by Technology: - Radiofrequency (RF) - Cryotherapy - Ultrasound or High Intensity Focused Ultrasound (HIFU) - Light or Laser - Electrical - Microwave - Others Ablation Technologies Market, by Application: - Cardiovascular - Gynecology - Oncology - Pain management - Urology - Ophthalmology - Others For more information visit http://www.researchandmarkets.com/research/z8pb7c/ablation
BSX: 11.45 (+0.01), MDT: 61.81 (-0.44), STJ: 56.74 (-0.54)

BSX January 2017 Options Begin Trading
DividendChannel.com - Mon Oct 13, 9:57AM CDT
Investors in Boston Scientific Corp. saw new options begin trading today, for the January 2017 expiration.
BSX: 11.45 (+0.01)

LINC, BSX, KNL, RBCAA, BBT Expected To Be Down Before Next Earnings Releases
M2 - Mon Oct 13, 2:39AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released in the coming weeks and determining how the stocks have performed Before their last 12 quarterly, 6 quarterly and December earnings reports. Lincoln Educational Services Corp (NASDAQ:LINC), Boston Scientific Corp (NYSE:BSX), Knoll Inc (NYSE:KNL), REPUBLIC BANCORP, INC. (NASDAQ:RBCAA), BB&T Corp (NYSE:BBT) are all expected to be Down Before their earnings are released. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php . The following stocks are expected to go Down Before earnings are released Tuesday:
BSX: 11.45 (+0.01), RBCAA: 24.40 (-0.08), BBT: 35.49 (-0.47), KNL: 17.88 (+0.21), LINC: 2.96 (+0.16)

Insider Trading Alert - BSX, FSL And ATRO Traded By Insiders
at The Street - Fri Oct 10, 9:00AM CDT
Stocks with insider trader activity include BSX, FSL and ATRO
BSX: 11.45 (+0.01), ATRO: 46.76 (+1.00), FSL: 16.60 (+0.45)

AngioDynamics Q1 Earnings & Revenues Beat, '15 View Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 10, 8:00AM CDT
For fiscal 2015, AngioDynamics Inc. (ANGO) raised its adjusted per share guidance to a range of 65 to 71 cents from the prior expectation of 64 to 70 cents, on the back of stronger than anticipated first-quarter results.
BSX: 11.45 (+0.01), ANGO: 15.65 (-0.14), ERB: 2.84 (+0.08)

tw telecom announces expansion of fibre network in Minneapolis-St Paul area
M2 - Fri Oct 10, 6:56AM CDT
tw telecom (Nasdaq:TWTC), a provider of Business Ethernet and networking solutions, announced on Thursday the expansion of its existing footprint in Minneapolis with service into St Paul, as well as the business communities in the western suburbs, the northern metro areas including Anoka County and south and east through Washington County including the St Croix Valley.
BSX: 11.45 (+0.01), TWTC: 37.50 (+0.10)

Boston Scientific's Heart Implant Device Wins FDA Panel Vote - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 09, 1:20PM CDT
Boston Scientific's (BSX) WATCHMAN Device is a catheter-delivered heart implant that blocks the left atrial appendage (LAA), so that the migration of blood clots from the LAA can be averted
BSX: 11.45 (+0.01), ICUI: 69.41 (+1.57), ZLTQ: 22.89 (+0.51), OSUR: 8.60 (+0.26)

$4.4 Billion Gastrointestinal Endoscopic Market in the U.S. and Europe Projected for 2020
GlobeNewswire - Thu Oct 09, 11:00AM CDT
via PRWEB - According to a new report by iData Research (http://www.idataresearch.com), the leading global authority in medical device market research, the U.S. and European gastrointestinal endoscopic market is expected to grow to over $4.4 Billion by 2020. This market is segmented into gastrointestinal (GI) endoscopes, capsule endoscopes, stenting devices, dilation devices, endoscopic retrograde cholangiopancreatography (ERCP) devices, biopsy forceps, polypectomy snares, hemostasis devices and enteral feeding devices. Market growth will primarily be driven by an increase in demand for gastrointestinal endoscopic procedures.
BSX: 11.45 (+0.01)

FDA Advisory Committee Panel Votes In Favor Of The WATCHMAN(TM) Left Atrial Appendage Closure Device
PR Newswire - Wed Oct 08, 6:59PM CDT
After reviewing updated data and analysis for the Boston Scientific Corporation (NYSE: BSX) WATCHMAN(TM) Left Atrial Appendage Closure (LAAC) Device, the U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel of the Medical Devices Advisory Committee voted in favor of the Device. By a vote of 6 to 5 (with 1 abstention) the Panel concluded that the benefits of the WATCHMAN Device outweigh the potential risks. Furthermore, the Panel voted that there is reasonable assurance that the Device is safe (12 yes to 0 no). On the question of reasonable assurance of effectiveness, the Panel vote was unfavorable (6 yes to 7 no). The Panel provided substantial input and guidance related to the proposed Indications for Use and target patient population. There was widespread agreement among the Panel members that the Device provides a much needed alternative to long-term anticoagulation for some patients. While not bound by this vote, the FDA takes Advisory Panel comments and recommendations into account when reviewing the WATCHMAN Device application. The company is committed to working with the FDA to address the Panel's comments.
BSX: 11.45 (+0.01)

Look for Shares of Boston Scientific to Potentially Pullback after Yesterday's 2.97% Rise
Comtex SmarTrend(R) - Wed Oct 08, 4:57PM CDT
Boston Scientific (NYSE:BSX) traded in a range yesterday that spanned from a low of $11.74 to a high of $12.15. Yesterday, the shares gained 3.0%, which took the trading range above the 3-day high of $12.00 on volume of 13.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BSX: 11.45 (+0.01)

SmarTrend Watching for Potential Pullback in Shares of Boston Scientific After 2.97% Gain
Comtex SmarTrend(R) - Wed Oct 08, 4:56PM CDT
Boston Scientific (NYSE:BSX) traded in a range yesterday that spanned from a low of $11.74 to a high of $12.15. Yesterday, the shares gained 3.0%, which took the trading range above the 3-day high of $12.00 on volume of 13.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BSX: 11.45 (+0.01)

Canada Gynecological Devices Market Outlook to 2020: Key players covered include Bayer, Hologic, Boston Scientific, Microsulis, Cook and Merit
M2 - Tue Oct 07, 5:20AM CDT
Research and Markets (http://www.researchandmarkets.com/research/rn2nsv/canada) has announced the addition of the "Canada Gynecological Devices Market Outlook to 2020" report to their offering. Our new report, "Canada Gynecological Devices Market Outlook to 2020", provides key market data on the Canada Gynecological Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Female Sterilization Devices (Transcervical Sterilization Devices (Micro-inserts) and Mechanical Sterilization Devices (Tubal Clips and Rings)), Endometrial Ablation Devices (Thermal Balloon, Hydrothermal Ablation (HTA), Bipolar Energy, Cryotherapy and Microwave Endometrial Ablation Devices) and Uterine Fibroid Embolization Agents (Poly Vinyl Alcohol Particles, Trisacryl Gelatin Microspheres and Gelatin Sponge). The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Gynecological Devices market wherever available. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Key Topics Covered: 1 List of Tables and Figures 2 Introduction 3 Gynecological Devices Market, Canada 4 Overview of Key Companies in Canada, Gynecological Devices Market 5 Appendix Companies Mentioned: - Conceptus, Inc. - Hologic, Inc. - CooperSurgical, Inc. - Cook Group Incorporated - Utah Medical Products, Inc. - Boston Scientific Corporation - Johnson & Johnson - Merit Medical Systems, Inc. - BSD Medical Corporation For more information visit http://www.researchandmarkets.com/research/rn2nsv/canada
BSX: 11.45 (+0.01), JNJ: 96.78 (-1.43), BSDM: 0.44 (+0.01), UTMD: 51.84 (+0.43), MMSI: 12.74 (+0.13), HOLX: 23.15 (-0.21)

Australia Non-Vascular Stents Market Outlook to 2020: Key players covered include Boston Scientific, Taewoong, Merit, Cook, PNN, Teleflex and C.R. Bard.
M2 - Tue Oct 07, 5:19AM CDT
Research and Markets (http://www.researchandmarkets.com/research/qz758b/australia) has announced the addition of the "Australia Non-Vascular Stents Market Outlook to 2020" report to their offering. Our new report, "Australia Non-Vascular Stents Market Outlook to 2020", provides key market data on the Australia Non-Vascular Stents market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Biliary Stents (Plastic Biliary Stents and Metal Biliary Stents (Metal Non-Covered Biliary Stents, Metal Partially Covered Biliary Stents and Metal Fully Covered Biliary Stents)), Gastrointestinal Stents (Fully Covered, Partially Covered and Non-Covered Gastrointestinal Stents), Airway Stents (Silicone Airway Stents and Metallic Airway Stents (Fully Covered and Uncovered Metallic Airway Stents) and Urinary Tract Stents ((Ureteral Stents (Metal, Polymer and Bioabsorbable Ureteral Stents), Prostate Stents (Metal, Polymer and Bioabsorbable Prostate Stents) and Urethral Stents (Metal, Polymer and Bioabsorbable Urethral Stents)). The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Non-Vascular Stents market wherever available. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. Key Topics Covered: 1. List of Tables and Figures 2 Introduction 3 Non-Vascular Stents Market, Australia 4 Overview of Key Companies in Australia, Non-Vascular Stents Market 5 Appendix Companies Mentioned: - Boston Scientific - C. R. Bard - Cook - Olympus - Covidien - Taewoong - Merit - ConMed For more information visit http://www.researchandmarkets.com/research/qz758b/australia
BSX: 11.45 (+0.01)

Brazil Gynecological Devices Market Outlook to 2020: Key players covered include Bayer Healthcare, Hologic, Boston Scientific, Microsulis, Cook and Merit
M2 - Tue Oct 07, 5:19AM CDT
Research and Markets (http://www.researchandmarkets.com/research/hxzlpw/brazil) has announced the addition of the "Brazil Gynecological Devices Market Outlook to 2020" report to their offering. Our new report, "Brazil Gynecological Devices Market Outlook to 2020", provides key market data on the Brazil Gynecological Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Female Sterilization Devices (Transcervical Sterilization Devices (Micro-inserts) and Mechanical Sterilization Devices (Tubal Clips and Rings)), Endometrial Ablation Devices (Thermal Balloon, Hydrothermal Ablation (HTA), Bipolar Energy, Cryotherapy and Microwave Endometrial Ablation Devices) and Uterine Fibroid Embolization Agents (Poly Vinyl Alcohol Particles, Trisacryl Gelatin Microspheres and Gelatin Sponge). The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Gynecological Devices market wherever available. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Key Topics Covered: 1 List of Tables and Figures 2 Introduction 3 Gynecological Devices Market, Brazil 4 Overview of Key Companies in Brazil, Gynecological Devices Market 5 Appendix Companies Mentioned: - Hologic - Merit Medical Systems - Cook Group Incorporated - Johnson & Johnson - Utah Medical Products - CooperSurgical - Boston Scientific - Conceptus - Richard Wolf For more information visit http://www.researchandmarkets.com/research/hxzlpw/brazil
BSX: 11.45 (+0.01), JNJ: 96.78 (-1.43), UTMD: 51.84 (+0.43), MMSI: 12.74 (+0.13), HOLX: 23.15 (-0.21)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Perform.AI Tests Whether Stores Can Sell to Agents

Updated Category News Views 85

Shopping bots are about to become one more fussy customer standing in the aisle, except this one reads machine-facing files, rejects broken checkout steps, and does not care how pretty the homepage looks. Perform.AI has launched a free UCP and ACP Readiness Checker aimed at online retailers that need to know whether AI agents can find products, purchase them, and follow...

Continue Reading
Weatherford Adds Grant Roach to Its Sports Deal Team

Updated Category News Views 69

Sports investing has reached that awkward middle age where everybody sees the runway, but few can explain exactly where the bumps are. Weatherford Capital’s decision to bring Grant Roach aboard as vice president is not a headline packed with transaction fireworks. It is, however, a pretty clear tell: the Tampa firm intends to put more bodies and more underwriting muscle...

Continue Reading
DEFSEC Tackles Nasdaq Bid Price Hurdle with Share Move

Updated Category News Views 68

Navigating Bid Price Deficiency Issues Well, it seems DEFSEC Technologies Inc. found themselves in a tricky spot last week. A nasty gram from Nasdaq’s Listing Qualifications Department pointing out that DEFSEC's shares had dipped below that $1.00 per share requirement for too long—a full 30 business days. Now, don't panic just yet. This isn't about the shares getting...

Continue Reading
Century's Florence Model Openings Put Arizona in Focus

Updated Category News Views 62

Six furnished houses in Florence may sound like a modest ribbon-cutting, but homebuilding is a business of small field signals before the quarterly numbers ever show up. Century Communities is scheduled to host a November grand opening for six model homes spanning two new communities in Florence, Arizona. For investors tracking NYSE:CCS, that is not a thesis by itself. It...

Continue Reading
ActivTrak's Fast 500 Rank Needs Investor Perspective

Updated Category News Views 60

Rank 488 is the sort of trophy that deserves a raised eyebrow, not confetti. ActivTrak made Deloitte's 2026 Technology Fast 500 after posting 101.1% revenue growth from 2022 through 2025, its sixth appearance on the list since 2020. That is real progress, and repeat recognition says this was not a one-quarter sugar high. Still, a Fast 500 ranking is a growth screen, not a...

Continue Reading
LG Channels UAE Push Tests the Free Streaming Model

Updated Category News Views 137

A television's idle screen is turning into contested real estate in the UAE. LG Channels is adding programming from Rakuten TV, Stingray and Red Bull TV to its free, ad-supported service, and that matters for more than somebody hunting a movie after dinner. This is a practical push to make webOS-powered screens more useful, more frequently used and, eventually, more...

Continue Reading
Misunderstood Brands Bets Small Cans Can Scale Growth

Updated Category News Views 99

A tiny cocktail can is a brutal little test of whether a spirits brand has legs. Misunderstood Brands is putting four 100mL offerings on the shelf just as its Wegmans distribution expands across the East Coast, and that combination matters more than another glossy flavor announcement. The company is trying to turn products people discovered in bars and restaurants into...

Continue Reading
Luxor Targets Device Chaos With Kwik IQ Hub Lockers

Updated Category News Views 86

A dead scanner at shift change can make an expensive digital rollout look downright foolish. Luxor Workspaces is aiming squarely at that unglamorous mess with its newly available Kwik IQ Hub smart-locker collection, introduced at the Connected Worker: Manufacturing Summit in Chicago on October 13–15. The pitch is not flashy: put shared radios, scanners, headsets,...

Continue Reading
First US Extends Buyback Clock Through Year-End 2027

Updated Category News Views 58

A buyback extension is not a thunderclap; it is a bank board keeping a useful tool within reach. First US Bancshares has pushed the expiration of its existing repurchase authorization from December 31, 2026, to December 31, 2027. That matters, but investors ought to resist turning a calendar change into a grand earnings prophecy. The company has bought back 2,122,972...

Continue Reading
Novo and nference Push Whole-Body Data Into Research

Updated Category News Views 89

Cardiometabolic medicine has spent too long staring at single numbers while the rest of the body keeps waving its arms. Novo Nordisk’s newly announced collaboration with nference is an attempt to widen that lens, combining Novo’s clinical-trial research with nference’s AI technology and federated healthcare data network. The target is not small: obesity, diabetes,...

Continue Reading

Top 5 Most Recently Viewed Articles

OFG Bancorp Reports Stellar Growth in 2024 Financial Results

Updated Category News Views 221

OFG Bancorp's Impressive Financial Results for 2024 OFG Bancorp (NYSE: OFG), the financial holding company for Oriental Bank, has reported robust financial performance for the fourth quarter and full year ended December 31, 2024. This remarkable growth marks an important milestone as the bank continues to enhance its services and strengthen its market positioning. Fourth...

Continue Reading
Innovative Dose Escalation Strategy for Infliximab Therapy

Updated Category News Views 404

Innovative Dose Escalation Strategy for Infliximab Therapy Celltrion, a prominent biopharmaceutical company based in Incheon, South Korea, recently unveiled exciting findings regarding the two-year efficacy of dose escalation therapy with subcutaneous infliximab, known as CT-P13 SC. These results were announced at the United European Gastroenterology (UEG) Week 2024. The...

Continue Reading
Understanding the Impact of Rising Repo Activity on Funding

Updated Category News Views 228

The Rising Repo Activity and Its Implications The recent rise in overnight repurchase agreements, commonly referred to as repos, has significantly influenced the financial landcape. This surge has put immense stress on banks that serve as intermediaries in these transactions, creating potential funding pressures at crucial periods such as quarter-ends and year-ends. What...

Continue Reading
Recent Lawsuit Over Securities at Perpetua Resources Corp. Highlights Shareholder Rights

Updated Category News Views 158

Understanding the Class Action Lawsuit Against Perpetua Resources Corp Levi & Korsinsky, LLP is raising awareness about a class action lawsuit impacting shareholders of Perpetua Resources Corp. This initiative is crucial for investors who experienced losses due to alleged securities fraud associated with the company's operations. Class Definition and Purpose The lawsuit...

Continue Reading
Exciting New Pickleball Kingdom Facility Set for Kentucky

Updated Category News Views 617

Exciting Announcement for Pickleball Enthusiasts Pickleball Kingdom, recognized as the world's largest indoor pickleball organization, is thrilled to announce its latest facility opening in Lexington, Kentucky. With a plan to cover an impressive 42,300 square feet, this state-of-the-art venue will feature 17 professional-grade indoor courts designed to deliver an ultimate...

Continue Reading